Literature DB >> 20632106

Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience.

William A Ross1, Chukwuma I Egwim, Michael J Wallace, Michael Wang, David C Madoff, Jeffrey H Lee.   

Abstract

BACKGROUND: Little information is available to guide clinicians on the optimal approach to managing obstructive jaundice in lymphoma patients. AIMS: The aim of this study was to review our experience in treating lymphoma patients with obstructive jaundice in order to develop guidelines as to the best interventional approach.
METHODS: We reviewed the medical records of all lymphoma patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) and/or percutaneous biliary drainage (PBD) for obstructive jaundice between June 2002 and October 2008.
RESULTS: We identified 35 lymphoma patients who underwent ERCP and/or PBD for obstructive jaundice. The mean age was 57.6 years. Most patients (66%) had diffuse large B-cell lymphoma. Stents were placed by ERCP in 25 patients and PBD in nine. Serum bilirubin levels normalized following ERCP or PBD in 29 of 33 (85%) patients with stricture. Stricture resolution occurred in 12 cases. Patients who had obstructive jaundice at the time of their lymphoma diagnosis had significantly longer mean overall survival following intervention than patients in whom obstructive jaundice developed later in the course of their disease (21.3 months vs. 4.5 months, P = 0.0001).
CONCLUSIONS: ERCP and/or PBD effectively normalized serum bilirubin levels. Plastic stents should be used in patients who have obstructive jaundice at the time of lymphoma diagnosis because these strictures tend to resolve before stent exchanges are necessary. For patients in whom obstructive jaundice develops later in the course of their disease, the limited prognosis often makes a single intervention with insertion of a plastic stent sufficient to provide adequate biliary decompression.

Entities:  

Mesh:

Year:  2010        PMID: 20632106     DOI: 10.1007/s10620-010-1310-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Trends in mortality from non-Hodgkin's lymphomas.

Authors:  Fabio Levi; Franca Lucchini; Eva Negri; Carlo La Vecchia
Journal:  Leuk Res       Date:  2002-10       Impact factor: 3.156

2.  Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.

Authors:  Elizabeth C Moser; Evert M Noordijk; Flora E van Leeuwen; Joke W Baars; José Thomas; Patrice Carde; Jacobus H Meerwaldt; Martine van Glabbeke; Hanneke C Kluin-Nelemans
Journal:  Haematologica       Date:  2006-10-17       Impact factor: 9.941

3.  Extrahepatic biliary obstruction by lymphoma.

Authors:  E Feller; F J Schiffman
Journal:  Arch Surg       Date:  1990-11

4.  Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival.

Authors:  A Schmassmann; E von Gunten; J Knuchel; U Scheurer; H F Fehr; F Halter
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

5.  Use of expandable metallic biliary stents in resectable pancreatic cancer.

Authors:  Sanjeev M Wasan; William A Ross; Gregg A Staerkel; Jeffrey H Lee
Journal:  Am J Gastroenterol       Date:  2005-09       Impact factor: 10.864

6.  Primary chemotherapy for obstructive jaundice caused by intermediate-grade non-Hodgkin lymphoma.

Authors:  D J Dudgeon; M Brower
Journal:  Cancer       Date:  1993-05-01       Impact factor: 6.860

7.  A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction.

Authors:  H Isayama; Y Komatsu; T Tsujino; N Sasahira; K Hirano; N Toda; Y Nakai; N Yamamoto; M Tada; H Yoshida; Y Shiratori; T Kawabe; M Omata
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 8.  Non-Hodgkin's lymphoma presenting with biliary tract obstruction. A discussion of seven patients and a review of the literature.

Authors:  P Fidias; R W Carey; M L Grossbard
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  The diagnosis and treatment of obstructive jaundice secondary to malignant lymphoma: a problem in multidisciplinary management.

Authors:  A W Boddie; B L Eisenberg; J D Mullins; A L Schlichtemeier
Journal:  J Surg Oncol       Date:  1980       Impact factor: 3.454

View more
  4 in total

1.  Metal stents and biliary obstruction secondary to lymphoma: a tale of caution.

Authors:  Johan C Bakken; Todd H Baron
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

Review 2.  Complications of lymphoma in the abdomen and pelvis: clinical and imaging review.

Authors:  Mihran Khdhir; Tamara El Annan; Mohammad Ali El Amine; Muhammed Shareef
Journal:  Abdom Radiol (NY)       Date:  2022-06-12

Review 3.  Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer.

Authors:  Takeshi Okamoto
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742

4.  Obstructive jaundice as an initial manifestation of non-hodgkin lymphoma: treatment dilemma and high mortality.

Authors:  Dhara Chaudhari; Sarah Khan; Atif Saleem; Tamarro Taylor; Chakradhar Reddy; Thomas Borthwick; Mark Young
Journal:  Case Rep Med       Date:  2013-05-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.